Loading organizations...
Nuna Incorporated has raised $90.0M across 2 funding rounds.
Key people at Nuna Incorporated.
Nuna Incorporated has raised $90.0M in total across 2 funding rounds.
Nuna Inc. develops cloud-based healthcare data analytics software enabling value-based care. Their platform facilitates financial innovation and operational efficiency for healthcare systems. The company also offers a patient-focused application for chronic condition management, leveraging expertise from creating the nation’s first comprehensive Medicaid dataset.
Jini Kim and David Chen co-founded Nuna in 2010. Kim's personal experience navigating healthcare for her brother, and her critical role stabilizing healthcare.gov, provided the core insight. She established Nuna, meaning "big sister," driven by a commitment to improving healthcare affordability and accessibility.
The company’s solutions serve government entities, employers, and health plans, enhancing care quality and efficiency. Patients utilize the Nuna App for chronic condition management. Nuna's overarching mission is to make high-quality healthcare universally affordable and accessible, striving to inform meaningful change.
Key people at Nuna Incorporated.
Nuna Incorporated has raised $90.0M in total across 2 funding rounds.
Nuna Incorporated's investors include Kleiner Perkins, Moonfire Ventures, Tribe Capital.
Nuna Incorporated has raised $90.0M across 2 funding rounds. Most recently, it raised $60.0M Series B in May 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2016 | $60M Series B | — | Kleiner Perkins, Moonfire Ventures, Tribe Capital | Announced |
| Dec 1, 2013 | $30M Series A | — | Kleiner Perkins, Moonfire Ventures, Tribe Capital | Announced |
# Nuna Incorporated: High-Level Overview
Nuna is a healthcare technology company that builds AI-powered patient engagement and data analytics solutions for value-based care.[1][3] Founded in 2010 and headquartered in San Francisco, Nuna operates at the intersection of clinical outcomes and operational efficiency, serving healthcare providers, payers, and health systems. The company's core product is a daily virtual coaching app that connects patients with their care teams while tracking health metrics, medication adherence, and daily activities.[1][5] Nuna has demonstrated measurable clinical impact—72% of patients starting the platform with uncontrolled blood pressure achieve control, with an average systolic pressure decrease of 14 mmHg, and the app maintains a 73% six-month active-user retention rate.[5]
The company addresses a critical healthcare challenge: the gap between clinical visits and patient behavior change. By embedding AI-driven guidance directly into patients' daily routines and connecting them to their providers, Nuna enables the continuous monitoring and intervention necessary for managing chronic diseases in value-based care models where outcomes—not volume—drive reimbursement.
# Origin Story
Nuna was founded in 2010 by Jini Kim and David Chen, two technologists with deep expertise in healthcare and data science.[2] Kim previously served as a product manager at Google Health and played a key role in stabilizing the Healthcare.gov rollout during the Obama administration—giving her firsthand experience with both the promise and complexity of digital health transformation.[2] Chen brought complementary strengths as a Senior Data Scientist at Netflix and a graduate of Stanford's biomedical informatics program, positioning him to architect the data infrastructure underlying Nuna's platform.[2]
The founding moment reflected a clear insight: healthcare needed better tools to bridge the gap between clinical knowledge and patient behavior. Rather than building another electronic health record or administrative system, Kim and Chen focused on the patient experience—creating technology that makes health management intuitive and rewarding. The company's early traction attracted prominent venture capital backing, including investment from Kleiner Perkins Caufield & Byers and John Doerr, who now serves as Chairman of Nuna's board.[2] This pedigree signaled confidence in the founders' vision and provided resources to scale.
# Core Differentiators
# Role in the Broader Tech Landscape
Nuna operates within a secular shift toward value-based care, where healthcare systems increasingly bear financial risk for patient outcomes rather than simply billing for services rendered. This structural change creates enormous demand for technology that enables continuous patient engagement and predictive analytics—exactly what Nuna provides.
The timing is particularly favorable. Healthcare providers are under pressure to reduce readmissions, manage chronic disease populations more effectively, and demonstrate ROI on digital health investments. Simultaneously, regulatory momentum (including CMS payment models tied to outcomes) and consumer familiarity with mobile health apps have normalized digital-first care delivery. Nuna sits at the convergence of these forces.
The company also reflects a broader maturation of healthcare AI: moving beyond hype toward clinically validated, operationally integrated solutions. Rather than positioning itself as a consumer wellness app, Nuna positions itself as enterprise healthcare infrastructure, competing in a category alongside companies like Innovaccer and Inovalon that serve providers and payers with data activation and analytics platforms.[1]
# Quick Take & Future Outlook
Nuna's trajectory suggests a company positioned to become a foundational platform in value-based care infrastructure. With $90M in funding and demonstrated clinical outcomes, the company has moved beyond proof-of-concept into the phase where scale and integration matter most.[2] The acquisition of CentraForce Health's analytics technology signals ambition to expand beyond patient engagement into predictive analytics—potentially allowing Nuna to help providers identify high-risk populations before intervention is needed.
The key question ahead is whether Nuna can maintain its clinical rigor while scaling across diverse healthcare systems with varying technical maturity and care models. Success requires not just building better technology, but embedding it into the workflows and incentive structures of large, complex organizations. The company's board—anchored by John Doerr and including Andy Slavitt, former Acting Administrator of CMS—suggests deep healthcare policy expertise that could prove invaluable in navigating this transition.
As value-based care becomes the dominant reimbursement model rather than an experiment, companies that can demonstrably improve outcomes while reducing costs will become indispensable. Nuna's clinical validation and provider-centric design position it well to capture that opportunity.
